196 related articles for article (PubMed ID: 15767620)
1. C-reactive protein levels are not associated with increased risk for colorectal cancer in women.
Zhang SM; Buring JE; Lee IM; Cook NR; Ridker PM
Ann Intern Med; 2005 Mar; 142(6):425-32. PubMed ID: 15767620
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and the risk of incident colorectal cancer.
Erlinger TP; Platz EA; Rifai N; Helzlsouer KJ
JAMA; 2004 Feb; 291(5):585-90. PubMed ID: 14762037
[TBL] [Abstract][Full Text] [Related]
3. Summaries for patients. Can a blood test help predict who is at risk for colorectal cancer?
Ann Intern Med; 2005 Mar; 142(6):I79. PubMed ID: 15767616
[No Abstract] [Full Text] [Related]
4. Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort.
Swede H; Hajduk AM; Sharma J; Rawal S; Rasool H; Vella AT; Tobet RE; Stevens RG
Int J Cancer; 2014 Apr; 134(8):1862-70. PubMed ID: 24122448
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.
Toriola AT; Cheng TY; Neuhouser ML; Wener MH; Zheng Y; Brown E; Miller JW; Song X; Beresford SA; Gunter MJ; Caudill MA; Ulrich CM
Int J Cancer; 2013 Jun; 132(11):2648-58. PubMed ID: 23161620
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
Izano M; Wei EK; Tai C; Swede H; Gregorich S; Harris TB; Klepin H; Satterfield S; Murphy R; Newman AB; Rubin SM; Braithwaite D;
Int J Cancer; 2016 Mar; 138(5):1118-28. PubMed ID: 26413860
[TBL] [Abstract][Full Text] [Related]
7. Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.
Nimptsch K; Aleksandrova K; Boeing H; Janke J; Lee YA; Jenab M; Bueno-de-Mesquita HB; Jansen EH; Tsilidis KK; Trichopoulou A; Weiderpass E; Wu C; Overvad K; Tjønneland A; Boutron-Ruault MC; Dossus L; Racine A; Kaaks R; Canzian F; Lagiou P; Trichopoulos D; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Johansson A; Van Guelpen B; Khaw KT; Wareham N; Peeters PH; Quirós JR; Venceslá García A; Molina-Montes E; Dorronsoro M; Chirlaque MD; Barricarte Gurrea A; Key TJ; Duarte-Salles T; Stepien M; Gunter MJ; Riboli E; Pischon T
Int J Cancer; 2015 Mar; 136(5):1181-92. PubMed ID: 25043606
[TBL] [Abstract][Full Text] [Related]
8. Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men.
Pirro M; Bergeron J; Dagenais GR; Bernard PM; Cantin B; Després JP; Lamarche B
Arch Intern Med; 2001 Nov; 161(20):2474-80. PubMed ID: 11700160
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of serum C-reactive protein and colorectal cancer risk in men.
Gunter MJ; Stolzenberg-Solomon R; Cross AJ; Leitzmann MF; Weinstein S; Wood RJ; Virtamo J; Taylor PR; Albanes D; Sinha R
Cancer Res; 2006 Feb; 66(4):2483-7. PubMed ID: 16489056
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
Pradhan AD; Manson JE; Rifai N; Buring JE; Ridker PM
JAMA; 2001 Jul; 286(3):327-34. PubMed ID: 11466099
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
[TBL] [Abstract][Full Text] [Related]
12. Baseline high-sensitivity C-reactive protein predicts the risk of incident ankylosing spondylitis: Results of a community-based prospective study.
Su J; Cui L; Yang W; Shi H; Jin C; Shu R; Li H; Zeng X; Wu S; Gao X
PLoS One; 2019; 14(2):e0211946. PubMed ID: 30768617
[TBL] [Abstract][Full Text] [Related]
13. Is C-reactive protein specific for vascular disease in women?
Rifai N; Buring JE; Lee IM; Manson JE; Ridker PM
Ann Intern Med; 2002 Apr; 136(7):529-33. PubMed ID: 11926788
[TBL] [Abstract][Full Text] [Related]
14. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.
Prizment AE; Anderson KE; Visvanathan K; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):297-307. PubMed ID: 21217085
[TBL] [Abstract][Full Text] [Related]
15. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men.
Chiu HM; Lin JT; Chen TH; Lee YC; Chiu YH; Liang JT; Shun CT; Wu MS
Am J Gastroenterol; 2008 Sep; 103(9):2317-25. PubMed ID: 18844617
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein and risk for colorectal cancer.
Mascitelli L; Pezzetta F
Ann Intern Med; 2005 Oct; 143(7):544; author reply 544. PubMed ID: 16204172
[No Abstract] [Full Text] [Related]
17. [C-reactive protein level and colorectal adenoma].
Park SK; Park DI; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim JE; Son HJ
Korean J Gastroenterol; 2008 Apr; 51(4):225-31. PubMed ID: 18516001
[TBL] [Abstract][Full Text] [Related]
18. The association between C-reactive protein levels and the risk for chronic kidney disease hospitalizations in adults of a remote Indigenous Australian community - A prospective cohort study.
Arnold LW; Hoy WE; Wang Z
Nephrology (Carlton); 2017 Sep; 22(9):699-705. PubMed ID: 27312245
[TBL] [Abstract][Full Text] [Related]
19. A prospective evaluation of C-reactive protein levels and colorectal adenoma development.
Gunter MJ; Cross AJ; Huang WY; Stanczyk FZ; Purdue M; Xue X; Schoen R; Limburg PJ; Schatzkin A; Sinha R; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):537-44. PubMed ID: 21212059
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein and fracture risk: European prospective investigation into Cancer Norfolk Study.
Ahmadi-Abhari S; Luben RN; Wareham NJ; Khaw KT
Bone; 2013 Sep; 56(1):67-72. PubMed ID: 23702388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
